{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:55:23Z","timestamp":1771232123018,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00292-019-0567-6","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T09:47:23Z","timestamp":1548755243000},"page":"36-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mesenchymale und gemischte Uterustumoren","Mesenchymal and mixed uterine tumors"],"prefix":"10.1007","volume":"40","author":[{"given":"S. F.","family":"Lax","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"567_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/978-1-4419-0489-8_10","volume-title":"Blaustein\u2019s pathology of the female genital tract","author":"C Zaloudek","year":"2011","unstructured":"Zaloudek C, Hendrickson MR, Soslow RA (2011) Mesenchymal tumors of the uterus. In: Kurman RJ, WEllenson LH, Ronnett BM (Hrsg) Blaustein\u2019s pathology of the female genital tract, 6.\u00a0Aufl. Springer, New York, S\u00a0453\u2013578","edition":"6"},{"key":"567_CR2","volume-title":"TNM Klassifikation maligner Tumoren","year":"2018","unstructured":"Wittekind C (Hrsg) (2018) TNM Klassifikation maligner Tumoren, 8.\u00a0Aufl. Wiley-VCH, Weinheim","edition":"8"},{"key":"567_CR3","first-page":"135","volume-title":"Tumours of the female reproductive organs","author":"E Oliva","year":"2014","unstructured":"Oliva E, Carcangiu ML, Carinelli SG, Ip P, Loening T, Longacre TA, Nucci MR, Prat J, Zaloudek CJ (2014) Mesenchymal tumours of the uterine corpus. In: Kurman RJ, Carcangiu ML, Herrington S, Young RH (Hrsg) Tumours of the female reproductive organs. IARC, Lyon, S\u00a0135\u2013147"},{"key":"567_CR4","volume-title":"Gynecologic and urologic pathology. Similarities, differences and challenges","author":"SF Lax","year":"2019","unstructured":"Lax SF (2019) Mesenchymal tumors of the female genital tract. In: Raspollini MR, Lopez-Beltran A (Hrsg) Gynecologic and urologic pathology. Similarities, differences and challenges. Cambridge University Press, Cambridge"},{"issue":"6","key":"567_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR (1994) Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18(6):535\u2013558","journal-title":"Am J Surg Pathol"},{"key":"567_CR6","volume-title":"Tumours of the breast and female genital organs. WHO classification of tumours","year":"2003","unstructured":"Tavassoli FA, Devilee P (Hrsg) (2003) Tumours of the breast and female genital organs. WHO classification of tumours. IARC, Lyon"},{"issue":"1","key":"567_CR7","first-page":"132A","volume":"14","author":"K Atkins","year":"2001","unstructured":"Atkins K, Bell SW, Kempson R, Hendrickson M (2001) Epitheloid smooth muscle tumors of the uterus. Mod Pathol 14(1):132A","journal-title":"Mod Pathol"},{"issue":"5","key":"567_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/modpathol.2017.185","volume":"31","author":"S Croce","year":"2018","unstructured":"Croce S, Ducoulombier A, Ribeiro A, Lesluyes T, Noel JC, Amant F, Guillou L, Stoeckle E, Devouassoux-Shisheboran M, Penel N, Floquet A, Arnould L, Guyon F, Mishellany F, Chakiba C, Cuppens T, Zikan M, Leroux A, Frouin E, Farre I, Genestie C, Valo I, MacGrogan G, Chibon F (2018) Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a\u00a0comprehensive array-genomic hybridization analysis of 77 tumors. Mod Pathol 31(5):816\u2013828. \n                    https:\/\/doi.org\/10.1038\/modpathol.2017.185","journal-title":"Mod Pathol"},{"issue":"2","key":"567_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ygyno.2012.11.021","volume":"128","author":"B Davidson","year":"2013","unstructured":"Davidson B, Abeler VM, Hellesylt E, Holth A, Shih Ie M, Skeie-Jensen T, Chen L, Yang Y, Wang TL (2013) Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma. Gynecol Oncol 128(2):349\u2013355. \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2012.11.021","journal-title":"Gynecol Oncol"},{"issue":"4","key":"567_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00292-009-1160-1","volume":"30","author":"S Lax","year":"2009","unstructured":"Lax S (2009) Mesenchymal uterine tumors. Leiomyomas. Pathologe 30(4):274\u2013283. \n                    https:\/\/doi.org\/10.1007\/s00292-009-1160-1","journal-title":"Pathologe"},{"issue":"10","key":"567_CR11","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/PAS.0000000000000249","volume":"38","author":"S Croce","year":"2014","unstructured":"Croce S, Young RH, Oliva E (2014) Uterine leiomyomas with bizarre nuclei: a\u00a0clinicopathologic study of 59 cases. Am J Surg Pathol 38(10):1330\u20131339. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000249","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"567_CR12","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","volume":"40","author":"M Miettinen","year":"2016","unstructured":"Miettinen M, Felisiak-Golabek A, Wasag B, Chmara M, Wang Z, Butzow R, Lasota J (2016) Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases. Am J Surg Pathol 40(12):1661\u20131669. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000703","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"567_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00428-018-2292-6","volume":"472","author":"L Siegler","year":"2018","unstructured":"Siegler L, Erber R, Burghaus S, Brodkorb T, Wachter D, Wilkinson N, Bolton J, Stringfellow H, Haller F, Beckmann MW, Hartmann A, Agaimy A (2018) Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Arch 472(5):789\u2013796. \n                    https:\/\/doi.org\/10.1007\/s00428-018-2292-6","journal-title":"Virchows Arch"},{"issue":"10","key":"567_CR14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0046-8177(93)90186-K","volume":"24","author":"TJ Colgan","year":"1993","unstructured":"Colgan TJ, Pendergast S, LeBlanc M (1993) The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues. Hum Pathol 24(10):1073\u20131077","journal-title":"Hum Pathol"},{"key":"567_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/PAS.0b013e318032125e","volume":"31","author":"PP Ip","year":"2007","unstructured":"Ip PP, Lam KW, Cheung CL et\u00a0al (2007) Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: A\u00a0clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J\u00a0Surg Pathol 31:1215\u20131224","journal-title":"Am J\u00a0Surg Pathol"},{"issue":"6","key":"567_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/jcp.2011.089664","volume":"64","author":"C Boyd","year":"2011","unstructured":"Boyd C, McCluggage WG (2011) Unusual morphological features of uterine leiomyomas treated with progestogens. J\u00a0Clin Pathol 64(6):485\u2013489. \n                    https:\/\/doi.org\/10.1136\/jcp.2011.089664","journal-title":"J Clin Pathol"},{"issue":"6","key":"567_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00428-018-2470-6","volume":"473","author":"J Ferreira","year":"2018","unstructured":"Ferreira J, Felix A, Lennerz JK, Oliva E (2018) Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 473(6):665\u2013678. \n                    https:\/\/doi.org\/10.1007\/s00428-018-2470-6","journal-title":"Virchows Arch"},{"key":"567_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001196","author":"JA Arias-Stella 3rd","year":"2018","unstructured":"Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S (2018) Novel PLAG1 gene rearrangement distinguishes a\u00a0subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors. Am J Surg Pathol. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000001196","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"567_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","volume":"41","author":"LN Hoang","year":"2017","unstructured":"Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S (2017) Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma. Am J Surg Pathol 41(1):12\u201324. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000721","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"567_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","volume":"36","author":"CH Lee","year":"2012","unstructured":"Lee CH, Marino-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M, Dal Cin P, Fletcher JA, Nucci MR (2012) The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a\u00a0histologically high-grade and clinically aggressive tumor. Am J Surg Pathol 36(5):641\u2013653. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e31824a7b1a","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"567_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","volume":"30","author":"S Chiang","year":"2017","unstructured":"Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA (2017) BCOR is a\u00a0robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 30(9):1251\u20131261. \n                    https:\/\/doi.org\/10.1038\/modpathol.2017.42","journal-title":"Mod Pathol"},{"issue":"4","key":"567_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/modpathol.2017.162","volume":"31","author":"N Lewis","year":"2018","unstructured":"Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr., Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S (2018) ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a\u00a0report of 17 cases of a\u00a0newly defined entity. Mod Pathol 31(4):674\u2013684. \n                    https:\/\/doi.org\/10.1038\/modpathol.2017.162","journal-title":"Mod Pathol"},{"issue":"7","key":"567_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/gcc.22057","volume":"52","author":"I Panagopoulos","year":"2013","unstructured":"Panagopoulos I, Thorsen J, Gorunova L, Haugom L, Bjerkehagen B, Davidson B, Heim S, Micci F (2013) Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation. Genes Chromosomes Cancer 52(7):610\u2013618. \n                    https:\/\/doi.org\/10.1002\/gcc.22057","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"567_CR24","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","volume":"36","author":"CH Lee","year":"2012","unstructured":"Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR (2012) Cyclin D1 as a\u00a0diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 36(10):1562\u20131570. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e31825fa931","journal-title":"Am J Surg Pathol"},{"key":"567_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000554","author":"WG McCluggage","year":"2018","unstructured":"McCluggage WG, Lee CH (2018) YWHAE-NUTM2A\/B translocated high-grade endometrial stromal sarcoma commonly expresses CD56 and CD99. Int J Gynecol Pathol. \n                    https:\/\/doi.org\/10.1097\/PGP.0000000000000554","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"567_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00428-018-2474-2","volume":"473","author":"X Matias-Guiu","year":"2018","unstructured":"Matias-Guiu X, Davidson B, Lax SF (2018) Can the classification of low-grade endometrial stromal tumors still be improved? Virchows Arch 473(6):663\u2013664. \n                    https:\/\/doi.org\/10.1007\/s00428-018-2474-2","journal-title":"Virchows Arch"},{"key":"567_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030056","author":"S Tuyaerts","year":"2018","unstructured":"Tuyaerts S, Amant F (2018) Endometrial stromal sarcomas: a revision of their potential as targets for immunotherapy. Vaccines (Basel). \n                    https:\/\/doi.org\/10.3390\/vaccines6030056","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"567_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","volume":"26","author":"E Oliva","year":"2002","unstructured":"Oliva E, Young RH, Amin MB, Clement PB (2002) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a\u00a0study of 54 cases emphasizing the importance of using a\u00a0panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26(4):403\u2013412","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"567_CR29","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/jcp.2006.044842","volume":"60","author":"DP Hurrell","year":"2007","unstructured":"Hurrell DP, McCluggage WG (2007) Uterine tumour resembling ovarian sex cord tumour is an immunohistochemically polyphenotypic neoplasm which exhibits coexpression of epithelial, myoid and sex cord markers. J\u00a0Clin Pathol 60(10):1148\u20131154","journal-title":"J Clin Pathol"},{"key":"567_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001153","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Childs TJ, Colgan TJ, Sung YS, Swanson D, Zhang L, Antonescu CR (2018) Uterine tumor resembling ovarian sex cord tumor: a distinct entity characterized by recurrent NCOA2\/3 gene fusions. Am J Surg Pathol. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000001153","journal-title":"Am J Surg Pathol"},{"key":"567_CR31","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/PAS.0b013e3181a7b9cf","volume":"33","author":"PN Staats","year":"2009","unstructured":"Staats PN, Garcia JJ, Dias-Santagata DC et\u00a0al (2009) Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J\u00a0Surg Pathol 33:1206\u20131212","journal-title":"Am J\u00a0Surg Pathol"},{"issue":"1","key":"567_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/pgp.0b013e318057faf5","volume":"27","author":"K Biermann","year":"2008","unstructured":"Biermann K, Heukamp LC, Buttner R, Zhou H (2008) Uterine tumor resembling an ovarian sex cord tumor associated with metastasis. Int J Gynecol Pathol 27(1):58\u201360","journal-title":"Int J Gynecol Pathol"},{"key":"567_CR33","volume-title":"Gynecologic and urologic pathology. Similarities, differences and challenges","author":"SF Lax","year":"2019","unstructured":"Lax SF (2019) Mixed epithelial and mesenchymal tumors of the uterus. In: Raspollini MR, Lopez-Beltran A (Hrsg) Gynecologic and urologic pathology. Similarities, differences and challenges. Cambridge University Press, Cambridge"},{"key":"567_CR34","first-page":"148","volume-title":"Tumours of the female reproductive organs","author":"M Wells","year":"2014","unstructured":"Wells M, Oliva E, Palacios J, Prat J (2014) Mixed epithelial and mesenchymal tumours of the uterine corpus. In: Kurman RJ, Carcangiu ML, Herrington S, Young RH (Hrsg) Tumours of the female reproductive organs. IARC, Lyon, S\u00a0148\u2013151"},{"issue":"3","key":"567_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00004347-199607000-00004","volume":"15","author":"RA Soslow","year":"1996","unstructured":"Soslow RA, Chung MH, Rouse RV, Hendrickson MR, Longacre TA (1996) Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study. Int J Gynecol Pathol 15(3):209\u2013216","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"567_CR36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/PAS.0000000000000428","volume":"39","author":"K Nemejcova","year":"2015","unstructured":"Nemejcova K, Kenny SL, Laco J, Skapa P, Stanek L, Zikan M, Kleiblova P, McCluggage WG, Dundr P (2015) Atypical polypoid adenomyoma of the uterus: an immunohistochemical and molecular study of 21 cases. Am J Surg Pathol 39(8):1148\u20131155. \n                    https:\/\/doi.org\/10.1097\/PAS.0000000000000428","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"567_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/PAS.0b013e318181a80d","volume":"33","author":"A Gallardo","year":"2009","unstructured":"Gallardo A, Prat J (2009) Mullerian adenosarcoma: a\u00a0clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 33(2):278\u2013288","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"567_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/his.13091","volume":"70","author":"P Ramalingam","year":"2017","unstructured":"Ramalingam P, Croce S, McCluggage WG (2017) Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology 70(3):359\u2013366. \n                    https:\/\/doi.org\/10.1111\/his.13091","journal-title":"Histopathology"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-019-0567-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-019-0567-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-019-0567-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T19:30:39Z","timestamp":1580239839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-019-0567-6"}},"subtitle":["Aktuelle \u00dcbersicht und praktische Aspekte","Current overview and practical aspects"],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s00292-019-0567-6","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"29 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0F.\u00a0Lax gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}